Smievoll AI - Search Results

1

Treatment of relapsing-remittent multiple sclerosis with recombinant human interferon-alfa-2a: design of a randomised, placebo-controlled, double blind trial in Norway.

Nyland H, Myhr KM, Lillås F, Smievoll AI, Riise T, Nortvedt M, Nilsen R. Nyland H, et al. Among authors: smievoll ai. Mult Scler. 1996 Jul;1(6):372-5. doi: 10.1177/135245859600100618. Mult Scler. 1996. PMID: 9345420 Clinical Trial.

2

Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis.

Myhr KM, Riise T, Green Lilleås FE, Beiske TG, Celius EG, Edland A, Jensen D, Larsen JP, Nilsen R, Nortvedt MW, Smievoll AI, Vedeler C, Nyland HI. Myhr KM, et al. Among authors: smievoll ai. Neurology. 1999 Mar 23;52(5):1049-56. doi: 10.1212/wnl.52.5.1049. Neurology. 1999. PMID: 10102427 Clinical Trial.

3

IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis.

Wergeland S, Beiske A, Nyland H, Hovdal H, Jensen D, Larsen JP, Marøy TH, Smievoll AI, Vedeler CA, Myhr KM. Wergeland S, et al. Among authors: smievoll ai. Eur J Neurol. 2005 Mar;12(3):171-5. doi: 10.1111/j.1468-1331.2004.01102.x. Eur J Neurol. 2005. PMID: 15693804 Clinical Trial.

4

Primary diffuse large B-cell lymphoma of the dura without systemic recurrence four years after diagnosis and successful therapy.

Berget E, Helgeland L, Lehmann AK, Smievoll AI, Vintermyr OK, Mørk SJ. Berget E, et al. Among authors: smievoll ai. Acta Oncol. 2013 Jun;52(5):1047-9. doi: 10.3109/0284186X.2012.731526. Epub 2012 Oct 16. Acta Oncol. 2013. PMID: 23072723 No abstract available.

5

[A 90-year-old woman with acute hemiparesis].

Sanaker PS, Aarhus M, Lund-Johansen M, Smievoll AI, Tzoulis C, Skeie GO. Sanaker PS, et al. Among authors: smievoll ai. Tidsskr Nor Laegeforen. 2006 Aug 10;126(15):1931-3. Tidsskr Nor Laegeforen. 2006. PMID: 16937574 Norwegian.

6

Frontoparietal activation during delayed visuospatial recall in patients with epilepsy due to hippocampal sclerosis.

Engelsen BA, Gramstad A, Thomsen T, Beneventi H, Ersland L, Smievoll AI, Lundervold A, Hugdahl K. Engelsen BA, et al. Among authors: smievoll ai. Epilepsy Behav. 2006 May;8(3):565-74. doi: 10.1016/j.yebeh.2006.02.010. Epub 2006 Apr 17. Epilepsy Behav. 2006. PMID: 16616647

7

Mr morphometry analysis of grey matter volume reduction in schizophrenia: association with hallucinations.

Neckelmann G, Specht K, Lund A, Ersland L, Smievoll AI, Neckelmann D, Hugdahl K. Neckelmann G, et al. Among authors: smievoll ai. Int J Neurosci. 2006 Jan;116(1):9-23. doi: 10.1080/00207450690962244. Int J Neurosci. 2006. PMID: 16318996 Clinical Trial.

8

[Use of MR in the diagnosis of multiple sclerosis].

Bakke SJ, Lilleås F, Smievoll AI, Myhr G, Nakstad PH, Bajic R, Larmo A. Bakke SJ, et al. Among authors: smievoll ai. Tidsskr Nor Laegeforen. 2003 May 15;123(10):1349-51. Tidsskr Nor Laegeforen. 2003. PMID: 12806675 Review. Norwegian. No abstract available.

9

Significant relation between MR measures of planum temporale area and dichotic processing of syllables in dyslexic children.

Hugdahl K, Heiervang E, Ersland L, Lundervold A, Steinmetz H, Smievoll AI. Hugdahl K, et al. Among authors: smievoll ai. Neuropsychologia. 2003;41(6):666-75. doi: 10.1016/s0028-3932(02)00224-5. Neuropsychologia. 2003. PMID: 12591024

10

[Thrombolytic therapy in acute cerebral infarction].

Thomassen L, Waje-Andreassen U, Naess H, Moen G, Smievoll AI. Thomassen L, et al. Among authors: smievoll ai. Tidsskr Nor Laegeforen. 2002 Sep 10;122(21):2095-7. Tidsskr Nor Laegeforen. 2002. PMID: 12555643 Free article. Norwegian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page